These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9825656)

  • 1. [TSH receptor antibodies in the recurrent goiter after surgical treatment of Graves-Basedow disease].
    Janowska J; Widala E; Zych F
    Pol Merkur Lekarski; 1998 May; 4(23):257-8. PubMed ID: 9825656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thyrotropin receptor antibodies (TRAb) as a test of surgical treatment effectiveness in Graves-Basedow's diseases].
    Bojarska-Szmygin A; Ciechanek R; Jezierska B; Zaorska-Rajca J
    Pol Merkur Lekarski; 2002 Sep; 13(75):196-9. PubMed ID: 12474569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [TSH receptor antibodies as a recurrence index of Graves disease treated with antithyroid drugs].
    Arqueros MC; el Tamer E; el Tamer S; Houssay AB
    Medicina (B Aires); 1991; 51(1):9-13. PubMed ID: 1921702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibodies against TSH receptors (TRAb) as indicators in prognosing the effectiveness of Tiamazol therapy for Grave's Disease].
    Bojarska-Szmygin A; Ciechanek R
    Wiad Lek; 2003; 56(7-8):303-7. PubMed ID: 14969154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
    Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
    Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Occurrence of TSH receptor antibodies and thyroid microsomal antibodies in Graves-Basedow disease].
    Paunković N; Paunković D
    Med Pregl; 1995; 48(1-2):10-4. PubMed ID: 8657049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications for surgical treatment of diffuse toxic goiter].
    Vetshev PS; Balabolkin MI; Petunina NA; Trukhina LV
    Khirurgiia (Mosk); 2000; (8):4-7. PubMed ID: 10996996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is the thyroidectomy a surgical standard procedure for therapy of Graves' disease?].
    Loick J; Schulz HG; Rupp KD; Hohlbach G
    Zentralbl Chir; 2005 Aug; 130(4):368-71. PubMed ID: 16103963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spontaneous hypothyroidism in 4 patients with Graves-Basedow disease].
    González-González A; Recio Cordova JM; Aznar Ondoño I; Del Monte Jarabo Bueno M
    Endocrinol Nutr; 2009 May; 56(5):273-6. PubMed ID: 19627750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of TSH receptor antibody determination].
    Gannage MH; Haddad F; Jambart S; Atallah C; Halaby G
    J Med Liban; 1996; 44(3):134-7. PubMed ID: 9296963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay.
    Hovens GC; Heemstra KA; Buiting AM; Stokkel MP; Karperien M; Ballieux BE; Pereira AM; Romijn JA; Smit JW
    Nucl Med Commun; 2007 Feb; 28(2):123-7. PubMed ID: 17198353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are porcine and human TSH receptor antibody measurements comparable?
    Zöphel K; von Landenberg P; Roggenbuck D; Wunderlich G; Kotzerke J; Lackner KJ
    Clin Lab; 2008; 54(1-2):1-8. PubMed ID: 18510037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease.
    Schott M; Morgenthaler NG; Fritzen R; Feldkamp J; Willenberg HS; Scherbaum WA; Seissler J
    Horm Metab Res; 2004 Feb; 36(2):92-6. PubMed ID: 15002058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of remission or relapse for Graves' hyperthyroidism by the combined determination of stimulating, blocking and binding TSH-receptor antibodies after the withdrawal of antithyroid drug treatment.
    Wallaschofski H; Miehle K; Mayer A; Tuschy U; Hentschel B; Paschke R
    Horm Metab Res; 2002 Jul; 34(7):383-8. PubMed ID: 12189586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial.
    Schott M; Hermsen D; Broecker-Preuss M; Casati M; Mas JC; Eckstein A; Gassner D; Golla R; Graeber C; van Helden J; Inomata K; Jarausch J; Kratzsch J; Miyazaki N; Moreno MA; Murakami T; Roth HJ; Stock W; Noh JY; Scherbaum WA; Mann K
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):566-73. PubMed ID: 19170704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
    Giovanella L; Ceriani L; Garancini S
    Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current topics on immunological laboratory tests-thyroid diseases].
    Iwatani Y
    Rinsho Byori; 2004 Sep; 52(9):751-8. PubMed ID: 15552935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.
    Hirooka Y; Li C; Takagi J; Gotoh M; Habu S; Yasaka-Nomura T; Ishihara R; Nakasone Y; Nakamura R; Morikawa R; Otake K; Nogimori T; Ishizuki Y
    Int J Clin Pharmacol Res; 2004; 24(4):111-6. PubMed ID: 15754915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.